Pharmacogenomic (PG) analysis for prediction of individual response to paclitaxel in 5-FU-refractory metastatic gastric cancer: Prediction formula of tumor response using novel marker genes and genotypes associated with the toxicity

R. Ikeda,Kazuhiro Yoshida,A. Takagane,A. Tsuburaya,O. Kobayashi,H. Sunouchi,Masaaki Matsukawa,Keiji Tanimoto,Keiko Hiyama,Masahiko Nishiyama

Pharmacogenomic (PG) analysis for prediction of individual response to paclitaxel in 5-FU-refractory metastatic gastric cancer: Prediction formula of tumor response using novel marker genes and genotypes associated with the toxicity

2016

R. Ikeda
Kazuhiro Yoshida
A. Takagane
A. Tsuburaya
O. Kobayashi
H. Sunouchi
Masaaki Matsukawa
Keiji Tanimoto
Keiko Hiyama
Masahiko Nishiyama

2538 Background: Taxanes offer hope for improving outcomes of metastatic gastric cancer patients including 5-FU failure cases, but the response remarkably varies among patients. We conducted this p...

Keywords:

Oncology
Gene
Toxicity
Pathology
Internal medicine
Refractory
Metastatic gastric cancer
Medicine
Pharmacogenomics
Paclitaxel
Genotype
tumor response

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations